KCTD21 antibody
Principal name
KCTD21 antibody
Alternative names for KCTD21 antibody
BTB/POZ domain-containing protein KCTD21
Available reactivities
Available hosts
Available applications
Western blot / Immunoblot (WB)
Background of KCTD21 antibody
- Kit Component:
- - KN308715G1, Kctd21 gRNA vector 1 in pCas-Guide vector
- KN308715G2, Kctd21 gRNA vector 2 in pCas-Guide vector
- KN308715D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Gerhard,D.S., Genome Res. 14 (10B), 2121-2127 (2004)
Human Brain; WB Suggested Anti-KCTD21 Antibody Titration: 0.2-1 ug/ml. Positive Control: Human brain; KCTD21 antibody - N-terminal region (ARP54466_P050) in Human Brain cells using Western Blot
Human Jurkat; WB Suggested Anti-KCTD21 Antibody Titration: 0.2-1 ug/ml. Positive Control: Jurkat cell lysate; KCTD21 antibody - middle region (ARP54467_P050) in Human Jurkat cells using Western Blot
WB Suggested Anti-KCTD21 Antibody Titration: 0.2-1 ug/ml; Positive Control: Human brain
WB Suggested Anti-KCTD21 Antibody Titration: 0.2-1 ug/ml; Positive Control: Jurkat cell lysate
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP306177 | KCTD21 |
||||
| Recombinant protein of human potassium channel tetramerisation domain containing 21 (KCTD21) | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY422476 | KCTD21 overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR219998L2V | Lenti ORF particles, Kctd21 (GFP-tagged) - Mouse potassium channel tetramerisation domain containing 21 (Kctd21), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€930.00
|
|
| OriGene Technologies, Inc. | ||
| MR219998L1V | Lenti ORF particles, Kctd21 (Myc-DDK-tagged) - Mouse potassium channel tetramerisation domain containing 21 (Kctd21), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€830.00
|
|
| OriGene Technologies, Inc. | ||
